[EN] 4-ETHYNYLPYRIDINE DERIVATIVES USEFUL AS GCN2 INHIBITORS<br/>[FR] DÉRIVÉS DE 4-ÉTHYNYLPYRIDINE UTILES EN TANT QU'INHIBITEURS DE GCN2
申请人:IP2IPO INNOVATIONS LTD
公开号:WO2021250399A1
公开(公告)日:2021-12-16
The invention provides compounds of formula I, wherein the substituents are as set out in further detail in the specification. The compounds are potent inhibitors of GCN2 and they have excellent pharmacokinetic properties. The compounds are useful for the treatment or prevention of a variety of conditions, particularly cancer. The invention further provides pharmaceutical compositions comprising the compounds of the invention and uses of the compounds and the compositions.
该发明提供了公式I的化合物,其中取代基的详细设置在说明书中进一步详细说明。这些化合物是GCN2的有效抑制剂,具有优异的药代动力学性质。这些化合物可用于治疗或预防各种疾病,特别是癌症。该发明还提供了包括该发明的化合物的药物组合物以及化合物和组合物的用途。